Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Filings indexed 2,580 across all filing types
Latest filing 2015-10-27 AGM Information
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
2015年第四次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as materials for the "2015 Fourth Extraordinary General Meeting of Shareholders" of Zhongyuan Xiehe Cell Gene Engineering Co., Ltd. It contains detailed agenda items, including proposals for the transfer of 90% equity of a controlling subsidiary and acquisition of 100% equity of another company, both described as related party transactions. The document includes meeting procedures, voting instructions, detailed descriptions of the transactions, financial data of the involved companies, asset valuation reports, and legal compliance statements. The content is focused on the agenda and materials for a shareholders meeting, specifically an Extraordinary General Meeting (EGM), rather than a full annual report or financial statement. It is not a voting results announcement, nor a proxy solicitation, but the meeting materials themselves. Therefore, the document fits the category of AGM Information (AGM-R), which includes presentations and materials shared during general meetings (including extraordinary meetings). The document length (9745 characters) and detailed content support this classification with high confidence.
2015-10-27 Chinese
关于转让控股子公司90%股权暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the transfer of 90% equity of a controlling subsidiary, including transaction details, asset valuation, related party information, financial data, and board approval procedures. It is not a full financial report but a specific transaction announcement involving a related party. The content focuses on the capital transaction and related disclosures, fitting the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a regulatory filing. Therefore, the classification is CAP with high confidence.
2015-10-22 Chinese
独立董事关于关联交易事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding related party transactions, including the transfer and acquisition of significant equity stakes. It references compliance with regulatory guidelines and company bylaws, and discusses the fairness and legality of the transactions. The document is relatively short (1003 characters) and focuses on governance and approval of related party transactions rather than presenting financial data or full reports. It is not an annual report, audit report, earnings release, or other financial report. It is also not a simple announcement of a report publication. The content fits best under Board/Management Information (MANG) as it involves board-level decisions and independent director opinions on corporate governance matters related to transactions.
2015-10-22 Chinese
北京投资管理有限公司审计报告
Audit Report / Information Classification · 100% confidence The document is titled "审计报告" (Audit Report) and contains detailed audit opinions, financial statements including balance sheet and profit and loss statement, and extensive notes on accounting policies and financial instruments. It references the audit standards and responsibilities of management and auditors, and provides an audit opinion on the financial statements for the period ending August 31, 2015. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The content matches the definition of an Audit Report / Information filing, which includes standalone audit reports and applied accounting principles, distinct from a full Annual Report. Therefore, the appropriate classification is AR (Audit Report / Information).
2015-10-22 Chinese
细胞基因公司拟转让所持投资公司股权所涉及的投资公司股东全部权益价值项目资产评估报告
Audit Report / Information Classification · 95% confidence The document is titled '资产评估报告' (Asset Valuation Report) and is issued by an asset appraisal company for a specific transaction involving the transfer of equity in a subsidiary company. It contains detailed valuation methodology, financial data, accounting policies, and legal disclaimers. The document is a formal asset valuation report used to estimate the market value of shareholder equity for a transaction purpose. It is not an annual or interim financial report, nor is it an announcement or a certification. It is a standalone valuation report related to a capital transaction (equity transfer). Given the nature of the document as an asset valuation report, it best fits under the category of Audit Report / Information (AR), which includes applied accounting principles and valuation reports related to financial assessments but excludes full annual reports. The document is substantive and detailed, not a brief announcement or a presentation.
2015-10-22 Chinese
天津鸿港投资有限公司审计报告
Audit Report / Information Classification · 100% confidence The document is titled '审计报告' which translates to 'Audit Report'. It contains detailed financial statements including balance sheets, profit and loss statements, cash flow statements, and notes to the financial statements. The text includes auditor responsibilities, management responsibilities, and an auditor's opinion on the financial statements for the periods ending December 31, 2014, and August 31, 2015. The presence of an auditor's opinion and detailed financial data confirms this is a standalone audit report rather than a full annual report or other filing. The document length is substantial (15,000 characters), indicating it is the full report, not just an announcement or certification. Therefore, the appropriate classification is Audit Report / Information (AR).
2015-10-22 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.